Surgery,Tissue Plasminogen Activator,Antiangiogenic Agents,and Age-Related Macular Degeneration Study: A Randomized Controlled Trial for Submacular Hemorrhage Secondary to Age-Related Macular Degeneration |
| |
| Affiliation: | 1. Department of Ophthalmology, University Hospital, Dijon, France;2. Department of Ophthalmology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France;3. Department of Ophthalmology, Intercommunal Hospital Center and Henri Mondor Hospital, Paris-Est Créteil University (UPEC, Paris XII University), Créteil, France;4. Department of Ophthalmology, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France;5. Department of Ophthalmology, Clinique Mathilde, Rouen, France;6. Department of Ophthalmology, Croix-Rousse Teaching Hospital, Hospices Civils de Lyon, Lyon, France;7. UMR5510 MATEIS, CNRS, INSA Lyon, Université Lyon 1, Villeurbanne, France;8. Department of Ophthalmology, Robert Debré Hospital, Reims, France;9. Department of Ophthalmology, Université Paris Cité, AP-HP, Lariboisière, Saint Louis and Adolphe de Rothschild Fondation Hospitals, Paris, France;10. Department of Clinical Research and Innovation (DRCI), Clinical Research Unit Methodological Support Network (USMR), University Hospital, Dijon, France |
| |
| Abstract: | |
| |
| Keywords: | Age-related macular degeneration Anti-VEGF agent Hemorrhage Pneumatic displacement Vitrectomy Vitreoretinal surgery AMD" },{" #name" :" keyword" ," $" :{" id" :" kwrd0040" }," $$" :[{" #name" :" text" ," _" :" age-related macular degeneration BCVA" },{" #name" :" keyword" ," $" :{" id" :" kwrd0050" }," $$" :[{" #name" :" text" ," _" :" best-corrected visual acuity CI" },{" #name" :" keyword" ," $" :{" id" :" kwrd0060" }," $$" :[{" #name" :" text" ," _" :" confidence interval DD" },{" #name" :" keyword" ," $" :{" id" :" kwrd0070" }," $$" :[{" #name" :" text" ," _" :" disc diameter IVT" },{" #name" :" keyword" ," $" :{" id" :" kwrd0080" }," $$" :[{" #name" :" text" ," _" :" intravitreal injection NEI-VFQ-25" },{" #name" :" keyword" ," $" :{" id" :" kwrd0090" }," $$" :[{" #name" :" text" ," _" :" 25-item National Eye Institute Visual Function Questionnaire PD" },{" #name" :" keyword" ," $" :{" id" :" kwrd0100" }," $$" :[{" #name" :" text" ," _" :" pneumatic displacement PPV" },{" #name" :" keyword" ," $" :{" id" :" kwrd0110" }," $$" :[{" #name" :" text" ," _" :" pars plana vitrectomy RCT" },{" #name" :" keyword" ," $" :{" id" :" kwrd0120" }," $$" :[{" #name" :" text" ," _" :" randomized controlled trial RPE" },{" #name" :" keyword" ," $" :{" id" :" kwrd0130" }," $$" :[{" #name" :" text" ," _" :" retinal pigment epithelium SD" },{" #name" :" keyword" ," $" :{" id" :" kwrd0140" }," $$" :[{" #name" :" text" ," _" :" spectral-domain sulfur hexafluoride SMH" },{" #name" :" keyword" ," $" :{" id" :" kwrd0160" }," $$" :[{" #name" :" text" ," _" :" submacular hemorrhage STAR" },{" #name" :" keyword" ," $" :{" id" :" kwrd0170" }," $$" :[{" #name" :" text" ," _" :" Surgery Tissue Plasminogen Activator" },{" #name" :" keyword" ," $" :{" id" :" kwrd0180" }," $$" :[{" #name" :" text" ," _" :" Antiangiogenic Agents, and Age-Related Macular Degeneration tPA" },{" #name" :" keyword" ," $" :{" id" :" kwrd0190" }," $$" :[{" #name" :" text" ," _" :" tissue plasminogen activator VA" },{" #name" :" keyword" ," $" :{" id" :" kwrd0200" }," $$" :[{" #name" :" text" ," _" :" visual acuity VEGF" },{" #name" :" keyword" ," $" :{" id" :" kwrd0210" }," $$" :[{" #name" :" text" ," _" :" vascular endothelial growth factor |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
